MétaCan
Menu
Back to cohort
Record W2619830557 · doi:10.1002/cam4.1083

Optimization of liposomal topotecan for use in treating neuroblastoma

2017· article· en· W2619830557 on OpenAlexafffund
Lina Chernov, Rebecca Deyell, Malathi Anantha, Nancy Dos Santos, Roger Gilabert‐Oriol, Marcel B. Bally

Bibliographic record

VenueCancer Medicine · 2017
Typearticle
Languageen
FieldMedicine
TopicNeuroblastoma Research and Treatments
Canadian institutionsUniversity of British ColumbiaCentre for Drug Research and DevelopmentBC Children's HospitalBC Cancer AgencyUniversity of British Columbia Hospital
FundersCanadian Institutes of Health ResearchDeutsche Forschungsgemeinschaft
KeywordsTopotecanLiposomePharmacokineticsPharmacologyNeuroblastomaChemistryDrugMedicineCell cultureChemotherapyInternal medicineBiochemistryBiology

Abstract

fetched live from OpenAlex

Abstract The purpose of this work was to develop an optimized liposomal formulation of topotecan for use in the treatment of patients with neuroblastoma. Drug exposure time studies were used to determine that topotecan (Hycamtin) exhibited great cytotoxic activity against SK ‐N‐ SH , IMR ‐32 and LAN ‐1 neuroblastoma human cell lines. Sphingomyelin ( SM )/cholesterol (Chol) and 1,2‐distearoyl‐ sn ‐glycero‐3‐phosphocholine ( DSPC )/Chol liposomes were prepared using extrusion methods and then loaded with topotecan by pH gradient and copper‐drug complexation. In vitro studies showed that SM /Chol liposomes retained topotecan significantly better than DSPC /Chol liposomes. Decreasing the drug‐to‐lipid ratio engendered significant increases in drug retention. Dose‐range finding studies on NRG mice indicated that an optimized SM /Chol liposomal formulation of topotecan prepared with a final drug‐to‐lipid ratio of 0.025 (mol: mol) was better tolerated than the previously described DSPC /Chol topotecan formulation. Pharmacokinetic studies showed that the optimized SM /Chol liposomal topotecan exhibited a 10‐fold increase in plasma half‐life and a 1000‐fold increase in AUC 0–24 h when compared with Hycamtin administered at equivalent doses (5 mg/kg). In contrast to the great extension in exposure time, SM /Chol liposomal topotecan increased the life span of mice with established LAN ‐1 neuroblastoma tumors only modestly in a subcutaneous and systemic model. The extension in exposure time may still not be sufficient and the formulation may require further optimization. In the future, liposomal topotecan will be assessed in combination with high‐dose radiotherapy such as 131 I‐metaiodobenzylguanidine, and immunotherapy treatment modalities currently used in neuroblastoma therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.251
Threshold uncertainty score0.349

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.070
GPT teacher head0.382
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueCancer MedicineSame topicNeuroblastoma Research and TreatmentsFrench-language works237,207